SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-182031
Filing Date
2023-07-05
Accepted
2023-07-05 17:07:06
Documents
16
Period of Report
2023-07-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d528523d8k.htm   iXBRL 8-K 40126
2 EX-99.1 d528523dex991.htm EX-99.1 23253
3 EX-99.2 d528523dex992.htm EX-99.2 3598
7 GRAPHIC g528523dsp014.jpg GRAPHIC 360634
8 GRAPHIC g528523dsp015.jpg GRAPHIC 339787
  Complete submission text file 0001193125-23-182031.txt   1169295

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA meip-20230705.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20230705_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20230705_pre.xml EX-101.PRE 11265
10 EXTRACTED XBRL INSTANCE DOCUMENT d528523d8k_htm.xml XML 3341
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 231070407
SIC: 2834 Pharmaceutical Preparations